Pharmaceutical Commerce - March/April 2012

A conversation with Jeffrey Berkowitz, Walgreens

June 12, 2012

The leading chain pharmacy steps up its role as healthcare provider and partner to pharma

Storing controlled substances safely and efficiently

March 30, 2012

Good design of vaults and cages for DEA-regulated materials calls for meeting regulatory requirements while accommodating operational practices

Bringing room-temperature pharma shipping under the 'CRT' umbrella

March 07, 2012

'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials

Biosimilars take a big step toward the marketplace

March 05, 2012

FDA's draft documents on biosimilar regulation move the prospect one step closer

Adding rigor to the adverse event reporting process

March 05, 2012

As FDA makes progress on an active surveillance system, drug manufacturers and third-party drug safety vendors navigate their own set of challenges

Supply chain issues for 2012

March 04, 2012

Tompkins International's annual preview of key pharma supply chain issues

Cancer care in the US -- looking back, looking forward

March 04, 2012

Begin thinking of your business as a 'disease' company vs. a 'drug' company

A conversation with Chris Smith, H. D. Smith

March 04, 2012

Pharmaceutical Commerce sat down with Chris Smith, president and COO; here's what he had to say.

USP ventures into standards for supply chain integrity

March 04, 2012

National organization proposes a draft standard; will hold workship in May

McKesson deepens ownership in Canadian retail pharmacy

February 28, 2012

Buys marketing rights to networks of independent pharmacies for C$920 million